{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:50:54Z","timestamp":1793677854900,"version":"4.5.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.pbb.2020.172870","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T11:21:03Z","timestamp":1580901663000},"page":"172870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"C","title":["A historical review of antidepressant effects of ketamine and its enantiomers"],"prefix":"10.1016","volume":"190","author":[{"given":"Yan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2020.172870_bb0005","series-title":"Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the Antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: A Double-blind, Placebo-Controlled, Cross-over, Randomized Clinical Trial. bioRxiv, 500959","author":"Abdallah","year":"2018"},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ijnp\/pyz041","article-title":"(R)-ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism","volume":"22","author":"Ago","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"issue":"7354","key":"10.1016\/j.pbb.2020.172870_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2020.172870_bb0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neubiorev.2017.03.010","article-title":"Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis","volume":"77","author":"Bartoli","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.pbb.2020.172870_bb0030","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity","volume":"28","author":"Becker","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2020.172870_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2020.172870_bb0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/da.22505","article-title":"Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice","volume":"33","author":"Bobo","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pbb.2020.172870_bb0045","series-title":"The CBHSQ Report","first-page":"1","article-title":"Emergency department visits involving phencyclidine (PCP)","author":"Bush","year":"2013"},{"key":"10.1016\/j.pbb.2020.172870_bb0050","article-title":"Gut microbiota-brain axis in depression: the role of neuroinflammation","author":"Carlessi","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ijnp\/pyx120","article-title":"Is metabolism of (R)-ketamine essential for the antidepressant effects?","volume":"21","author":"Chaki","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2020.172870_bb0060","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/ijms20061270","article-title":"Role of serotonergic system in the antidepressant actions of mGlu2\/3 receptor antagonists: similarity to ketamine","volume":"20","author":"Chaki","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.pbb.2020.172870_bb0065","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.addbeh.2013.01.014","article-title":"Effects of chronic ketamine use on frontal and medial temporal cognition","volume":"38","author":"Chan","year":"2013","journal-title":"Addict. Behav."},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0070","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ijnp\/pyy053","article-title":"No sex-specific differences in the acute antidepressant actions of (R)-ketamine in an inflammation model","volume":"21","author":"Chang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172870_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172870_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-019-01012-1","article-title":"Lack of dopamine D1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","author":"Chang","year":"2020","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0085","first-page":"952","article-title":"Interaction between N-methyl-D-aspartate receptor antagonists and imipramine in shock-induced depression","volume":"37","author":"Chaturvedi","year":"1999","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.pbb.2020.172870_bb0090","article-title":"Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study","author":"Correia-Melo","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1213\/00000539-196601000-00007","article-title":"Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581","volume":"45","author":"Corssen","year":"1966","journal-title":"Anesth. Analg."},{"issue":"8","key":"10.1016\/j.pbb.2020.172870_bb0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2020.172870_bb0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger. 1965","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.pbb.2020.172870_bb0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/schbul\/sbs011","article-title":"Phencyclidine\/schizophrenia: one view toward the past, the other to the future","volume":"38","author":"Domino","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pbb.2020.172870_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of Ci-581, a new dissociative anesthetic in man","volume":"6","author":"Domino","year":"1965","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2020.172870_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/bja\/aev215","article-title":"Ketamine: a growing global health-care need","volume":"115","author":"Dong","year":"2015","journal-title":"Br. J. Anaesth."},{"issue":"F1000 Faculty Rev","key":"10.1016\/j.pbb.2020.172870_bb0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172870_bb0135","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","author":"Fava","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2020.172870_bb0140","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/npp.2015.233","article-title":"The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN","volume":"41","author":"Fukumoto","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.pbb.2020.172870_bb0150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/aps.2016.5","article-title":"Ketamine use in current clinical practice","volume":"37","author":"Gao","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","article-title":"Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism","volume":"228","author":"Gigliucci","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172870_bb0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.forsciint.2015.04.024","article-title":"Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability","volume":"252","author":"Giorgetti","year":"2015","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-pharmtox-010617-052811","article-title":"Molecular pharmacology and neurobiology of rapid-acting antidepressants","volume":"59","author":"Gould","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0253-7176.175121","article-title":"Rapid resolution of grief with IV infusion of ketamine: a unique phenomenological experience","volume":"38","author":"Gowda","year":"2016","journal-title":"Indian J. Psychol. Med."},{"issue":"4","key":"10.1016\/j.pbb.2020.172870_bb0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41467-018-08168-9","article-title":"Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects","volume":"10","author":"Hare","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0185","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1176\/appi.ajp.2016.16040411","article-title":"Detrimental side effects of repeated ketamine infusions in the brain","volume":"173","author":"Hashimoto","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2020.172870_bb0190","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","article-title":"Ketamine\u2019s antidepressant action: beyond NMDA receptor inhibition","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pbb.2020.172870_bb0195","series-title":"Rapid Antidepressant Activity of Ketamine Beyond NMDA Receptor, the NMDA Receptors","first-page":"69","author":"Hashimoto","year":"2017"},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2020.172870_bb0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00406-019-01061-6","article-title":"Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressants","volume":"269","author":"Hashimoto","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2020.172870_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.12.003","article-title":"Impact of age on optimal dose of antidepressants","volume":"18","author":"Hashimoto","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb7065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","article-title":"Reduction of dopamine D2\/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.","volume":"267","author":"Hashimoto","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0215","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.biopsych.2017.12.007","article-title":"What are the causes for discrepancies of antidepressant actions of (2R,6R)-hydroxynorketamine?","volume":"84","author":"Hashimoto","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2020.172870_bb0220","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00406-018-0922-2","article-title":"Is (S)-norketamine an alternative antidepressant for esketamine?","volume":"269","author":"Hashimoto","year":"2018","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2020.172870_bb0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","article-title":"Ketamine: its mechanism(s) of action and unusual clinical uses","volume":"77","author":"Hirota","year":"1996","journal-title":"Br. J. Anaesth."},{"issue":"20","key":"10.1016\/j.pbb.2020.172870_bb0230","first-page":"2775","article-title":"Phencyclidine--angel dust","volume":"125","author":"Hoiseth","year":"2005","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"10.1016\/j.pbb.2020.172870_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2018.12.001","article-title":"Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression","volume":"176","author":"Huang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2020.172870_bb0240","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","article-title":"Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity","volume":"69","author":"Imre","year":"2006","journal-title":"Brain Res. Bull."},{"issue":"31","key":"10.1016\/j.pbb.2020.172870_bb0245","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016674","article-title":"A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.pbb.2020.172870_bb0250","article-title":"Esketamine: a glimmer of hope in treatment-resistant depression","author":"Kaur","year":"2019","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.pbb.2020.172870_bb0255","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.pbb.2020.172870_bb0260","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1073\/pnas.1916570117","article-title":"Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents","volume":"117","author":"Klein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.pbb.2020.172870_bb0270","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2020.172870_bb0280","series-title":"Drugs, Clubs and Young People","first-page":"91","article-title":"On ketamine: in and out of the K hole","author":"Lankenau","year":"2016"},{"issue":"3","key":"10.1016\/j.pbb.2020.172870_bb0285","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(95)00155-P","article-title":"Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)","volume":"52","author":"Layer","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172870_bb0290","article-title":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","author":"Leal","year":"2020","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"key":"10.1016\/j.pbb.2020.172870_bb0295","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Front. Hum. Neurosci."},{"issue":"5994","key":"10.1016\/j.pbb.2020.172870_bb0300","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pbb.2020.172870_bb0305","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","article-title":"Dopamine D2\/3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.172870_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.psyneuen.2016.11.031","article-title":"Oxidative stress, inflammation and treatment response in major depression","volume":"76","author":"Lindqvist","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.pbb.2020.172870_bb0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-015-4128-2","article-title":"Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression","volume":"233","author":"Liu","year":"2016","journal-title":"Psychopharmacology"},{"issue":"Pt 1","key":"10.1016\/j.pbb.2020.172870_bb0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"17","key":"10.1016\/j.pbb.2020.172870_bb0325","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1111\/bph.13222","article-title":"Ketamine and phencyclidine: the good, the bad and the unexpected","volume":"172","author":"Lodge","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056053","article-title":"Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2020.172870_bb0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/jm00326a019","article-title":"The synthesis of phencyclidine and other 1-arylcyclohexylamines","volume":"8","author":"Maddox","year":"1965","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.pbb.2020.172870_bb0340","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172870_bb0345","doi-asserted-by":"crossref","first-page":"l1810","DOI":"10.1136\/bmj.l1810","article-title":"Measles cases rise 300% globally in first few months of 2019","volume":"365","author":"Mahase","year":"2019","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0924-977X(92)90034-6","article-title":"Effects of MK-801 and antidepressant drugs in the forced swimming test in rats","volume":"2","author":"Maj","year":"1992","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.pbb.2020.172870_bb0355","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.biopsych.2019.02.008","article-title":"Concurrent use of buprenorphine, methadone, or naltrexone does not inhibit ketamine\u2019s antidepressant activity","volume":"85","author":"Marton","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2020.172870_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22126","article-title":"(R)- and (S)-ketamine induce differential fMRI responses in conscious rats","volume":"73","author":"Masaki","year":"2019","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb0365","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0091-3057(93)90374-3","article-title":"Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats","volume":"46","author":"Meloni","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.pbb.2020.172870_bb0370","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"History of anaesthesia: the ketamine story - past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"Eur. J. Anaesthesiol."},{"issue":"7\u20138","key":"10.1016\/j.pbb.2020.172870_bb0375","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Test. Anal."},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0380","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2020.172870_bb0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.pbb.2020.172870_bb0390","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.pbb.2020.172870_bb0395","first-page":"549","article-title":"New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors","volume":"45","author":"Papp","year":"1993","journal-title":"Pol. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pbb.2020.172870_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90516-9","article-title":"Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression","volume":"263","author":"Papp","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(00)00063-2","article-title":"The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review","volume":"87","author":"Petrie","year":"2000","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pbb.2020.172870_bb0410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16060-7","article-title":"Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model","volume":"7","author":"Qu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40268-015-0081-0","article-title":"Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature","volume":"15","author":"Reinstatler","year":"2015","journal-title":"Drugs R&D"},{"issue":"9","key":"10.1016\/j.pbb.2020.172870_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw028","article-title":"Inflammation models of depression in rodents: relevance to psychotropic drug discovery","volume":"19","author":"Remus","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2020.172870_bb0430","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/npp.2016.193","article-title":"Balancing the promise and risks of ketamine treatment for mood disorders","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","article-title":"Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-ketamine","volume":"21","author":"Shirayama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2020.172870_bb0445","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2020.172870_bb0440","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0450","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0455","first-page":"68","article-title":"Evaluation of ketamine HCl for anti-depressant activity","volume":"214","author":"Sofia","year":"1975","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"20","key":"10.1016\/j.pbb.2020.172870_bb0460","first-page":"25","article-title":"Ketamine: a review","volume":"20","author":"Stevenson","year":"2005","journal-title":"Update in Anaesthesia"},{"key":"10.1016\/j.pbb.2020.172870_bb0465","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ynstr.2018.09.001","article-title":"On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods","volume":"9","author":"Strong","year":"2018","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.pbb.2020.172870_bb0470","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1038\/tp.2016.21","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172870_bb0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","article-title":"Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine","volume":"172","author":"Tian","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"11","key":"10.1016\/j.pbb.2020.172870_bb0480","first-page":"1031","article-title":"Lack of antidepressant effects of low-voltage-sensitive T-type calcium channel blocker ethosuximide in a chronic social defeat stress model: comparison with (R)-ketamine","volume":"21","author":"Tian","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pbb.2020.172870_bb0490","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","article-title":"Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval","volume":"6","author":"Turner","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2020.172870_bb0495","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/acschemneuro.7b00074","article-title":"Classics in chemical neuroscience: ketamine","volume":"8","author":"Tyler","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0500","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","article-title":"Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)-and (R)-ketamine in healthy volunteers using positron emission tomography (PET)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172870_bb0505","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2019.09.064","article-title":"Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress","volume":"260","author":"Wang","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.pbb.2020.172870_bb0510","first-page":"537","article-title":"Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849\u2014a competitive antagonist of NMDA receptors","volume":"47","author":"Wedzony","year":"1995","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172870_bb0515","series-title":"WHO Model List of Essential Medicines: 17th List","author":"WHO","year":"2011"},{"key":"10.1016\/j.pbb.2020.172870_bb0520","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","author":"WHO","year":"2017"},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb0525","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2020.172870_bb0530","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2020.172870_bb0535","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41380-019-0503-4","article-title":"Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism","volume":"24","author":"Williams","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"22","key":"10.1016\/j.pbb.2020.172870_bb0540","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.2174\/1381612824666180730104707","article-title":"Rapid-acting antidepressants","volume":"24","author":"Witkin","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2020.172870_bb0545","series-title":"The SAGE Handbook of Drug & Alcohol Studies: Biological Approaches","first-page":"177","article-title":"Ketamine: The pharmacokinetics and pharmacodynamics in misusing populations","author":"Wolff","year":"2016"},{"key":"10.1016\/j.pbb.2020.172870_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111904","article-title":"Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model","volume":"368","author":"Xiong","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.pbb.2020.172870_bb0555","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41386-018-0084-y","article-title":"(2R,6R)-hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","volume":"43","author":"Yamaguchi","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0560","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03009734.2012.724118","article-title":"Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test","volume":"118","author":"Yang","year":"2013","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.pbb.2020.172870_bb0565","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2020.172870_bb0570","doi-asserted-by":"crossref","first-page":"pyw080","DOI":"10.1093\/ijnp\/pyw080","article-title":"Antidepressant effects of (+)-MK-801 and (\u2212)-MK-801 in the social defeat stress model","volume":"19","author":"Yang","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172870_bb0575","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2016.03.034","article-title":"Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","volume":"239","author":"Yang","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2020.172870_bb0580","article-title":"Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2020.172870_bb0585","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","article-title":"Possible role of gut-microbiota in the antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2020.172870_bb0590","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.biopsych.2018.05.007","article-title":"AMPA receptor activation-independent antidepressant actions of ketamine metabolite (S)-norketamine","volume":"84","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0595","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin\u2013independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"7692","key":"10.1016\/j.pbb.2020.172870_bb0600","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2020.172870_bb0605","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41398-019-0379-8","article-title":"Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0610","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2020.172870_bb0615","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamapsychiatry.2018.3990","article-title":"Association of combined naltrexone and ketamine with depressive symptoms in a case series of patients with depression and alcohol use disorder","volume":"76","author":"Yoon","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"7604","key":"10.1016\/j.pbb.2020.172870_bb0620","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pbb.2020.172870_bb0625","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.pbb.2020.172870_bb0630","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2020.172870_bb0635","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2020.172870_bb0640","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.biopsych.2018.11.006","article-title":"Lack of opioid system in the antidepressant actions of ketamine","volume":"85","author":"Zhang","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0645","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14737175.2019.1554434","article-title":"An update on ketamine and its two enantiomers as rapid-acting antidepressants","volume":"19","author":"Zhang","year":"2019","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.pbb.2020.172870_bb0690","article-title":"Efficacy of anticonvulsant ethosuximide for major depressive disorder: a randomized, placebo-control clinical trial","author":"Zhang","year":"2020","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"key":"10.1016\/j.pbb.2020.172870_bb0650","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172870_bb0695","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"23","key":"10.1016\/j.pbb.2020.172870_bb0655","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2020.172870_bb0660","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/1570159X14666160119094646","article-title":"Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets","volume":"14","author":"Zhang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pbb.2020.172870_bb0665","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1038\/tp.2017.112","article-title":"Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis","volume":"7","author":"Zhang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2020.172870_bb0670","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ijnp\/pyx100","article-title":"5-hydroxytryptamine-independent antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"21","author":"Zhang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172870_bb0675","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41598-018-22449-9","article-title":"Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.pbb.2020.172870_bb0680","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1007\/s00213-018-5017-2","article-title":"Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model","volume":"235","author":"Zhang","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172870_bb0685","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41398-019-0571-x","article-title":"Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress","volume":"9","author":"Zhang","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2020.172870_bb0700","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172870_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(19)30521-8","article-title":"Esketamine as a treatment for paediatric depression: questions of safety and efficacy","author":"Zimmermann","year":"2020","journal-title":"Lancet Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720300289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720300289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:36:18Z","timestamp":1758774978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305720300289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":142,"alternative-id":["S0091305720300289"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172870","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A historical review of antidepressant effects of ketamine and its enantiomers","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"172870"}}